Kezar Life Sciences KZR
KZR
$7.29 +0.00 (+0.00%)
At close: May 11, 2026 · 4:00 PM EDT

Kezar Life Sciences, Inc. (KZR) EBT Margin (2023)

Kezar Life Sciences (KZR) posted EBT Margin of 373.94% for Q3 2023.

Kezar Life Sciences, Inc. (KZR) EBT Margin (2023) Analysis & Trends

Kezar Life Sciences has reported EBT Margin for 1 years, with the latest figure at 373.94% in Q3 2023.

  • Quarterly EBT Margin changed N/A year-over-year to 373.94% in Q3 2023, while the trailing twelve-month figure through Dec 2024 was 1334.36% (up 29533.0% YoY) and the FY2023 annual result came in at 2612.3%, changed N/A from the prior year.
  • EBT Margin steadied at 373.94% in Q3 2023 per KZR's latest filing.
  • Over five years, EBT Margin peaked at 373.94% in Q3 2023 and troughed at 373.94% in Q3 2023.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2023 -373.94%